Back to Trials
NCT06135870Recruiting

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

Johns Hopkins University

Start Date

11/1/2023

Completion Date

12/31/2027

Summary

The investigators are evaluating the role of senescent cells in uterine fibroids.

Detailed Description

Uterine fibroids are prevalent tumors of uterus characterized by excessive fibrotic tissues. Using new cutting-edge computational methods, the investigators have found that small groups of senescent cells in fibroids work in concert with immune cells to produce soluble factors in fibroid tissues to create a feed-forward loop leading to fibrosis. This project seeks to unravel key cell-cell communication networks involving senescent and immune cells in fibroids to develop new treatments for uterine fibroids.

Eligibility Criteria

Age Range: 18 years to 55 years

Inclusion Criteria: * Subjects must be women above the age of ≥18 - ≤55 years. * Women with suspected uterine fibroids. * Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum. * Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information. Exclusion Criteria: * Unwilling to sign the consent form or complete questionnaire. * Pregnancy. * Cancer of the uterus

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

FibroidLeiomyoma

Locations

Johns Hopkins Hospital

Baltimore, Maryland 21287

United States